PT  - JOURNAL ARTICLE
AU  - Liu, Yang
AU  - Daley, Sean
AU  - Evdokimova, Viktoria N.
AU  - Zdobinski, David D.
AU  - Potter, Douglas M.
AU  - Butterfield, Lisa H.
TI  - Hierarchy of α Fetoprotein (AFP)-Specific T Cell Responses in Subjects with AFP-Positive Hepatocellular Cancer
AID  - 10.4049/jimmunol.177.1.712
DP  - 2006 Jul 01
TA  - The Journal of Immunology
PG  - 712--721
VI  - 177
IP  - 1
4099  - http://www.jimmunol.org/content/177/1/712.short
4100  - http://www.jimmunol.org/content/177/1/712.full
SO  - J. Immunol.2006 Jul 01; 177
AB  - We identified a series of immunodominant and subdominant epitopes from α fetoprotein (AFP), restricted by HLA-A*0201, which are recognized by the human T cell repertoire. The four immunodominant epitopes have been tested for immunogenicity in vivo, in HLA-A*0201+AFP+ advanced stage hepatocellular cancer (HCC) patients, and have activated and expanded AFP-specific IFN-γ-producing T cells in these patients, despite high serum levels of this self Ag. Here, we have examined the frequency, function, and avidity of the T cells specific for subdominant epitopes from AFP. We find that T cells specific for several of these epitopes are of similar or higher avidity than those specific for immunodominant epitopes. We then tested the peripheral blood of subjects ex vivo with different levels of serum AFP for the hierarchy of response to epitopes from this Ag and find that HCC patients have detectable frequencies of circulating IFN-γ-producing AFP-specific CD8+ T cells to both immunodominant and subdominant epitopes. We find the immunodominant and subdominant peptide-specific T cells to be differentially expanded with different modes of Ag presentation. Whereas spontaneous and AFP protein-stimulated responses show evidence for immunodominance, AdVhAFP-transduced dendritic cell-stimulated responses were broader and not skewed. Importantly, these data identify subdominant epitopes from AFP that can activate high-avidity T cells, and that can be detected and expanded in HCC subjects. These subdominant epitope-specific T cells can also recognize tumor cells and may be important therapeutically.